Patient-Reported Discontinuation of Endocrine Therapy and Related Adverse Effects Among Women With Early-Stage Breast Cancer

BACKGROUND: Approximately 20% to 50% of women diagnosed with hormone receptor–positive breast cancer discontinue endocrine therapy early; most reports come from automated pharmacy data or small self-report evaluations. We conducted a larger self-report evaluation of endocrine therapy discontinuation...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Aiello Bowles, Erin J., Boudreau, Denise M., Chubak, Jessica, Yu, Onchee, Fujii, Monica, Chestnut, Janet, Buist, Diana S.M.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Clinical Oncology 2012
Témata:
Health Care Delivery
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3500489/
https://ncbi.nlm.nih.gov/pubmed/23598850
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JOP.2012.000543
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky